These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 934715)

  • 21. [Effect of alpha-methyldopa in single and divided doses on the circadian rhythm of arterial pressure in hypertensive patients].
    Carpentiere G; Castello F; Marino S
    Clin Ter; 1984 Mar; 108(6):497-502. PubMed ID: 6233068
    [No Abstract]   [Full Text] [Related]  

  • 22. Mechanism of the hypotensive action of methyldopa in normal and immunosympathectomized rats.
    Ayitey-Smith E; Varma DR
    Br J Pharmacol; 1970 Oct; 40(2):186-93. PubMed ID: 5492891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modification of the cardiovascular effects of L-dopa by decarboxylase inhibitors.
    Watanabe AM; Parks LC; Kopin IJ
    J Clin Invest; 1971 Jun; 50(6):1322-8. PubMed ID: 5578236
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiovascular effects of GR117289, a novel angiotensin AT1 receptor antagonist.
    Hilditch A; Hunt AA; Gardner CJ; Twissell DJ; Polley J; Travers A; Drew GM; Middlemiss D; Ross BC; Robertson MJ
    Br J Pharmacol; 1994 Jan; 111(1):137-44. PubMed ID: 8012689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of oxprenolol and methyldopa in hypertension. A within-patient double-blind trial.
    Barritt DW; Marshall AJ; Heaton S
    Lancet; 1976 Mar; 1(7958):503-5. PubMed ID: 55780
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interaction of some drugs on the pharmacokinetics or pharmacodynamics of MPC-1304, a dihydropyridine Ca2+ antagonist.
    Nakano M; Miyoshi K; Umeno Y; Yoshida K; Nishizaki J; Miyake H
    Arch Int Pharmacodyn Ther; 1996; 331(2):109-23. PubMed ID: 8937623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of SK & F 64139, a phenylethanolamine-N-methyltransferase inhibitor, on centrally mediated cardiovascular effects of alpha-methyldopa and clonidine.
    Gerold M; Haeusler G
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Dec; 321(4):276-81. PubMed ID: 6132343
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chlorpromazine interactions with guanethidine and alpha-methyldopa: effects on arterial pressure control and heart rate in renovascular hypertensive rats.
    Rankin GO; Watkins BE; Sawutz DG
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):130-40. PubMed ID: 7165417
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alpha-Monofluoromethyldopa (MFMD) in combination with L-DOPA Effects on tissue catecholamines and blood pressure in rats.
    Johansson P; Henning M
    Naunyn Schmiedebergs Arch Pharmacol; 1982 Oct; 321(1):28-31. PubMed ID: 7144925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Captopril, alone and in combination with hydrochlorothiazide, on responses to upright tilt in conscious dogs.
    Baum T; Vander Vliet G; Glennon JC
    Arch Int Pharmacodyn Ther; 1981 Jul; 252(1):139-46. PubMed ID: 7030243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Time-course of the anti-hypertensive action of atenolol: comparison of response to first dose and to maintained oral administration.
    Leonetti G; Terzoli L; Bianchini C; Sala C; Zanchetti A
    Eur J Clin Pharmacol; 1980 Nov; 18(5):365-74. PubMed ID: 7002567
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of the stereoisomers of the alpha 2-adrenergic agonist medetomidine on systemic and coronary hemodynamics in conscious dogs.
    Schmeling WT; Kampine JP; Roerig DL; Warltier DC
    Anesthesiology; 1991 Sep; 75(3):499-511. PubMed ID: 1679615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The significance of the relative potencies of norepinephrine and alpha-methylnoradrenaline for the mode of action of alpha-methyldopa.
    Trinker FR
    J Pharm Pharmacol; 1971 Apr; 23(4):306-8. PubMed ID: 4396912
    [No Abstract]   [Full Text] [Related]  

  • 34. Mechanism of the tachycardia following systemic alpha-methyldopa administration in conscious rats.
    van der Maas ML; Head GA; de Jong W
    J Cardiovasc Pharmacol; 1986; 8(5):1014-9. PubMed ID: 2429074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of methyldopa on brain cholinergic neurons involved in cardiovascular regulation. A study in conscious spontaneously hypertensive rats.
    Buccafusco JJ
    Hypertension; 1984; 6(5):614-21. PubMed ID: 6500669
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect on resting blood pressure and blood pressure homeostasis of short-term administration of the alpha 1-adrenergic receptor antagonist, trimazosin, in hypertension.
    Sampieri L; Cuspidi C; Boselli L; Angioni L; Castiglioni G; Zanchetti A; Mancia G
    Cardiovasc Drugs Ther; 1988 Jan; 1(5):535-42. PubMed ID: 2908716
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat.
    Finch L; Haeusler G
    Br J Pharmacol; 1973 Feb; 47(2):217-28. PubMed ID: 4722038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential role of brain ascending noradrenergic bundles in the circulatory effects of alpha-methyldopa and clonidine.
    Van den Buuse M; Head GA; Korner PI
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):112-9. PubMed ID: 7678665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence that alpha-methylepinephrine is an antihypertensive metabolite of alpha-methyldopa.
    Goldberg MR; Tung CS; Ring M; Oates JA; Gerkens JF; Robertson D
    Clin Exp Hypertens A; 1982; 4(4-5):595-604. PubMed ID: 7105433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A centrally mediated peripheral hypotensive effect of alpha-methyldopa.
    Ingenito AJ; Barrett JP; Procita L
    J Pharmacol Exp Ther; 1970 Dec; 175(3):593-9. PubMed ID: 5489916
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.